Details for New Drug Application (NDA): 050617
✉ Email this page to a colleague
The generic ingredient in ERYGEL is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050617
Tradename: | ERYGEL |
Applicant: | Mylan |
Ingredient: | erythromycin |
Patents: | 0 |
Pharmacology for NDA: 050617
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 050617
Suppliers and Packaging for NDA: 050617
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERYGEL | erythromycin | GEL;TOPICAL | 050617 | NDA | Mylan Pharmaceuticals Inc. | 0378-8075 | 0378-8075-60 | 1 TUBE in 1 CARTON (0378-8075-60) / 60 g in 1 TUBE |
ERYGEL | erythromycin | GEL;TOPICAL | 050617 | NDA | Mylan Pharmaceuticals Inc. | 0378-8075 | 0378-8075-93 | 1 TUBE in 1 CARTON (0378-8075-93) / 30 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 2% | ||||
Approval Date: | Oct 21, 1987 | TE: | AT | RLD: | Yes |
Complete Access Available with Subscription